Quarterly Report

Amylyx Pharmaceuticals, Inc. Filed 2022-05-12 Acc 0000950170-22-009695

Documents 1

2022-08-11 10-Q Quarterly Report
2022-05-12 10-Q Quarterly Report
2022-05-12 8-K Results of operations
2022-05-06 4 Co-Chief Executive Officer acquired 334,520 shares (option exercise)
2022-05-06 4 Co-Chief Executive Officer acquired 334,520 shares (option exercise)
2022-05-05 4 10% owner acquired 5,955,889 shares (conversion)
2022-05-05 3 Initial Statement of Ownership

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading amlx-20220331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…